Literature DB >> 20167930

Lung endothelial dysfunction in congestive heart failure: role of impaired Ca2+ signaling and cytoskeletal reorganization.

Alexander Kerem1, Jun Yin, Stephanie M Kaestle, Julia Hoffmann, Axel M Schoene, Baljit Singh, Hermann Kuppe, Mathias M Borst, Wolfgang M Kuebler.   

Abstract

RATIONALE: Congestive heart failure (CHF) frequently results in remodeling and increased tone of pulmonary resistance vessels. This adaptive response, which aggravates pulmonary hypertension and thus, promotes right ventricular failure, has been attributed to lung endothelial dysfunction.
OBJECTIVE: We applied real-time fluorescence imaging to identify endothelial dysfunction and underlying molecular mechanisms in an experimental model of CHF induced by supracoronary aortic banding in rats. METHODS AND
RESULTS: Endothelial dysfunction was evident in lungs of CHF rats as impaired endothelium-dependent vasodilation and lack of endothelial NO synthesis in response to mechanical stress, acetylcholine, or histamine. This effect was not attributable to downregulation of endothelial NO synthase. Imaging of the cytosolic Ca(2+) concentration ([Ca(2+)](i)) revealed a singular impairment of endothelial [Ca(2+)](i) homeostasis and signaling characterized by a lack of [Ca(2+)](i) oscillations and deficient or attenuated [Ca(2+)](i) responses to mechanical stress, histamine, acetylcholine, or thapsigargin. Reconstitution of a [Ca(2+)](i) signal by ionophore treatment restored endothelial NO production, but lack of endothelial responsiveness was not primarily attributable to downregulation of Ca(2+) influx channels in CHF. Rather, we identified a massive remodeling of the endothelial cytoskeleton in the form of an increased expression of beta-actin and F-actin formation which contributed critically to endothelial dysfunction in CHF because cytoskeletal disruption by cytochalasin D largely reconstituted endothelial [Ca(2+)](i) signaling and NO production.
CONCLUSIONS: Our findings characterize a unique scenario of endothelial dysfunction in CHF that is caused by a singular impairment of [Ca(2+)](i) signaling, and identify cytoskeletal reorganization as a major regulator of endothelial signaling and function.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20167930     DOI: 10.1161/CIRCRESAHA.109.210542

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  14 in total

1.  Pulmonary vascular mechanical consequences of ischemic heart failure and implications for right ventricular function.

Authors:  Jennifer L Philip; Thomas M Murphy; David A Schreier; Sydney Stevens; Diana M Tabima; Margie Albrecht; Andrea L Frump; Timothy A Hacker; Tim Lahm; Naomi C Chesler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-02-15       Impact factor: 4.733

Review 2.  Transient receptor potential channels and regulation of lung endothelial permeability.

Authors:  Patricia C Villalta; Mary I Townsley
Journal:  Pulm Circ       Date:  2013-12       Impact factor: 3.017

Review 3.  TRPV4: physiological role and therapeutic potential in respiratory diseases.

Authors:  Neil M Goldenberg; Krishnan Ravindran; Wolfgang M Kuebler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-10-24       Impact factor: 3.000

Review 4.  Models and Molecular Mechanisms of World Health Organization Group 2 to 4 Pulmonary Hypertension.

Authors:  Ping Yu Xiong; Francois Potus; Winnie Chan; Stephen L Archer
Journal:  Hypertension       Date:  2017-11-20       Impact factor: 10.190

5.  Rho kinase modulates postnatal adaptation of the pulmonary circulation through separate effects on pulmonary artery endothelial and smooth muscle cells.

Authors:  Cristina M Alvira; David J Sukovich; Shu-Chen Lyu; David N Cornfield
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-08-13       Impact factor: 5.464

Review 6.  Endothelial actions of atrial and B-type natriuretic peptides.

Authors:  Michaela Kuhn
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 7.  Understanding the Pathobiology of Pulmonary Hypertension Due to Left Heart Disease.

Authors:  Jessica H Huston; Sanjiv J Shah
Journal:  Circ Res       Date:  2022-04-28       Impact factor: 23.213

8.  Nanomedicines for Endothelial Disorders.

Authors:  Bomy Lee Chung; Michael J Toth; Nazila Kamaly; Yoshitaka J Sei; Jacob Becraft; Willem J M Mulder; Zahi A Fayad; Omid C Farokhzad; YongTae Kim; Robert Langer
Journal:  Nano Today       Date:  2015-12-01       Impact factor: 20.722

9.  Ascending aortic constriction in rats for creation of pressure overload cardiac hypertrophy model.

Authors:  Ajith Kumar Gs; Binil Raj; Kumar S Santhosh; G Sanjay; Chandrasekharan Cheranellore Kartha
Journal:  J Vis Exp       Date:  2014-06-29       Impact factor: 1.355

10.  Altered Hemodynamics and End-Organ Damage in Heart Failure: Impact on the Lung and Kidney.

Authors:  Frederik H Verbrugge; Marco Guazzi; Jeffrey M Testani; Barry A Borlaug
Journal:  Circulation       Date:  2020-09-08       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.